A critical review on the dissemination of PH and stimuli-responsive polymeric nanoparticular systems to improve drug delivery in cancer therapy
S Bhattacharya, BG Prajapati, S Singh - Critical Reviews in Oncology …, 2023 - Elsevier
Stimuli-responsive nanocarriers have the potential to revolutionize cancer treatment by
allowing precise delivery of drugs to the site of disease. The use of polymeric nanocarriers …
allowing precise delivery of drugs to the site of disease. The use of polymeric nanocarriers …
Labyrinthin expression is associated with poor prognosis in patients with non-small-cell lung cancer
Simple Summary Adenocarcinomas represent nearly 40% of all cancer types, and account
for more than 70% of cancer-related deaths. Labyrinthin (LAB) is a novel cancer neoantigen …
for more than 70% of cancer-related deaths. Labyrinthin (LAB) is a novel cancer neoantigen …
Topology and adenocarcinoma cell localization dataset on the labyrinthin diapeutic biomarker
A Sharma, M Babich, T Li, JA Radosevich - BMC research notes, 2023 - Springer
Objective The discovery and characterization of tumor associated antigens is increasingly
important to advance the field of immuno-oncology. In this regard, labyrinthin has been …
important to advance the field of immuno-oncology. In this regard, labyrinthin has been …
Integrating Immunotherapy and Nanotechnology in Advanced Drug Delivery Systems for Precision Cancer Therapy
VJ Krishna, L Swathi, SS Lakshmi - Journal of Clinical and Pharmaceutical …, 2024 - jcpr.in
This review article investigates recent advancements in drug delivery systems, with a
specific emphasis on integrating nanotechnology and immunotherapy for precision cancer …
specific emphasis on integrating nanotechnology and immunotherapy for precision cancer …
Topology and adenocarcinoma cell localization dataset on the labyrinthin biomarker
M Babich, A Sharma, T Li, JA Radosevich - bioRxiv, 2021 - biorxiv.org
The discovery and characterization of tumor associated antigens is increasingly important to
advance the field of immuno-oncology. Data on the 1) topology, 2) sequence analyses, 3) …
advance the field of immuno-oncology. Data on the 1) topology, 2) sequence analyses, 3) …
The inhibitory effect of human umbilical cord mesenchymal stem cells expressing anti-HAAH scFv-sTRAIL fusion protein on glioma
T Xue, X Wang, J Ru, L Zhang, H Yin - Frontiers in Bioengineering …, 2022 - frontiersin.org
Glioma is the most common malignant intracranial tumor with low 5-year survival rate. In this
study, we constructed a plasmid expressing anti-HAAH single-chain antibody and sTRAIL …
study, we constructed a plasmid expressing anti-HAAH single-chain antibody and sTRAIL …
[PDF][PDF] Unveiling the Promise of Cancer Neoanfigens: A New Fronfier in Immunotherapy
A Sharma, M Babich, JA Radosevich - J Oncology. 2024; 4 (2) - journalononcology.org
Cancer is not only one of the leading causes of mortality and morbidity worldwide, but it is
also a large economic burden on the world's population. Tumour heterogeneity restricts the …
also a large economic burden on the world's population. Tumour heterogeneity restricts the …